Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma-Reference-Cited by-同舟云学术

Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma

Published:2018-11-13 Issue:2 Volume:120 Page:165-171
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Mazzaferro Vincenzo,El-Rayes Bassel F.,Droz dit Busset Michele,Cotsoglou Christian,Harris William P.,Damjanov Nevena,Masi Gianluca,Rimassa Lorenza,Personeni Nicola,Braiteh Fadi,Zagonel Vittorina,Papadopoulos Kyriakos P.,Hall Terence,Wang Yunxia,Schwartz Brian,Kazakin Julia,Bhoori Sherrie,de Braud Filippo,Shaib Walid L.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-018-0334-0.pdf

Reference40 articles.

1. Rizvi, S., Khan, S. A., Hallemeier, C. L., Kelley, R. K. & Gores, G. J. Cholangiocarcinoma—evolving concepts and therapeutic strategies. Nat. Rev. Clin. Oncol. 15, 95–111 (2018).

2. Dodson, R. M. et al. Intrahepatic cholangiocarcinoma: management options and emerging therapies. J. Am. Coll. Surg. 217, 736–750 (2013).

3. Razumilava, N. & Gores, G. J. Cholangiocarcinoma. Lancet 383, 2168–2179 (2014).

4. Valle, J. et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N. Engl. J. Med. 362, 1273–1281 (2010).

5. Hezel, A. F. & Zhu, A. X. Systemic therapy for biliary tract cancers. Oncologist 13, 415–423 (2008).

Cited by 295 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and antitumor activity of a novel FGFR2-selective degrader to overcome resistance of the FGFR2V564F gatekeeper mutation based on a pan-FGFR inhibitor;European Journal of Medicinal Chemistry;2024-09

2. Advances in Personalized Oncology;Cancers;2024-08-16

3. The Recent Trends of Systemic Treatments and Locoregional Therapies for Cholangiocarcinoma;Pharmaceuticals;2024-07-08

4. Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver (AFEF);Liver International;2024-07-05

5. Facts and Hopes in the Systemic Therapy of Biliary Tract Carcinomas;Clinical Cancer Research;2024-06-27